R

RA Capital Management, L.P.

164 employees

RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.

Investor insights

Countries invested in

united states1

Sectors invested in

Biotechnology272
Health Care192
Therapeutics122
Pharmaceutical104
Medical89
Health Diagnostics43
Life Science42
Biopharma42
Medical Device28
Genetics24
biotechnology12
Wellness10
Oncology10
Artificial Intelligence9
oncology9
Drug Development8
Personal Health8
Sepsis7
Cell Therapy7
cancer6

Funding rounds participated in

$70M sweet spot round size

Most of their 315 investments are in rounds between $42M and $106M

Investor type

Private Equity Firm
Venture Capital

Basic info

Industry

investment management

Sectors

Biotechnology
Financial Services
Finance
Lifesciences
Healthcare
Medical
Investment Management
Life Science
Venture Capital

Date founded

2004

Investments made

V

Vaxess Technologies raised $9M on September 13, 2023

Investors: Ulu Ventures, The Engine, Global Health Investment Corporation and RA Capital Management, L.P.

M

Mariana Oncology raised $175M on September 7, 2023

Investors: Surveyor Capital, Nextech Invest, Forbion, Atlas Ventures and RA Capital Management, L.P.

U

Undisclosed raised $210M on September 6, 2023

Investors: GV, Atlas Venture, Lightstone Ventures, S.R. One Ltd and RA Capital Management, L.P.

S

Star Therapeutics raised $90M on September 5, 2023

Investors: Qatar Investment Authority, Westlake Village BioPartners®, Sofinnova Ventures, Russia technology fund, Redmile Group, Soleus Capital Management, L.P., New Leaf Venture Partners, NYBC Ventures, OrbiMed Advisors and RA Capital Management, L.P.

C

COMPASS Pathways raised $125M on August 16, 2023

Investors: Vivo Capital, Soleus Capital Management, L.P., Laurion Capital Management LP, Partner Fund Management, Surveyor Capital, Logos Global Management, LP, TCG X, Armistice Capital LLC and RA Capital Management, L.P.

A

AN2 Therapeutics raised $70M on August 15, 2023

Investors: TCG X, Avidity Partners, Adage Capital Management, Surveyor Capital, Marshall Wace and RA Capital Management, L.P.

T

Taysha Gene Therapies raised $150M on August 14, 2023

Investors: RTW Investments, LP, Octagon Capital Advisors, GordonMD Global Investments LP, PBM Capital Group, TCG X, The Invus Group, B Capital Group and RA Capital Management, L.P.

C

CG Oncology raised $105M on August 2, 2023

Investors: Decheng Capital, Foresite Capital, Malin Corporation plc, Longitude Capital, TCG X, Avidity Partners and RA Capital Management, L.P.

C

CG Oncology raised $105M on August 2, 2023

Investors: Decheng Capital, Avidity Partners, TCG X, Foresite Capital, Malin Corporation plc, Longitude Capital and RA Capital Management, L.P.

S

Septerna raised $150M on July 11, 2023

Investors: Goldman Sachs Asset Management, The Invus Group, Third Rock Ventures, Woodline Partners LP, Soleus Capital Management, L.P., Samsara BioCapital, Logos Global Management, LP, Vertex Ventures HC and RA Capital Management, L.P.

FAQ